Cataract Clinical Trial
— GUSTOOfficial title:
The Effect of Counseling in Cataract Screening: Guangdong Uptake of Surgery Trial
The purpose of this study is:
1. To determine whether an educational intervention designed based on studies in the area
is effective in increasing acceptance of surgery and presentation to the hospital, when
adjusting for a number of potential determinants of service uptake;
2. To assess short-term impact of the educational intervention on knowledge about cataract
and attitudes toward locally-available surgical services.
| Status | Completed |
| Enrollment | 434 |
| Est. completion date | June 2011 |
| Est. primary completion date | June 2011 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 50 Years and older |
| Eligibility |
Inclusion Criteria: - thought by the examiner to have age-related or myopic cataract in one or both eyes - pinhole-corrected visual acuity less than or equal to 6/18. Exclusion Criteria: - traumatic cataract - inability to give informed consent due to dementia or other reasons. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| China | Zhongshan Ophthalmic Center | Guangzhou | Guangdong |
| Lead Sponsor | Collaborator |
|---|---|
| Sun Yat-sen University | Helen Keller International, Swarthmore College |
China,
Ellwein LB, Lepkowski JM, Thulasiraj RD, Brilliant GE. The cost effectiveness of strategies to reduce barriers to cataract surgery. The Operations Research Group. Int Ophthalmol. 1991 May;15(3):175-83. — View Citation
Tan L. Increasing the volume of cataract surgery: an experience in rural China. Community Eye Health. 2006 Dec;19(60):61-3. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Decision to Undergo Cataract Surgery (Surgery Acceptance) | Measured as a percentage of subjects who decide to undergo cataract surgery within 6 months after screening (positive) out of total subjects. | within 6 months after screening examination | No |
| Secondary | Attendance at Hospital for Pre-operative Examination | Measured as a percentage of people who presented to the hospital within 6 months after screening (positive) out of total subjects. | within 6 months after screening examination | No |
| Secondary | Knowledge That Cataract Can be Treated | Measured as a percentage of subjects who correctly answer the question in a questionnaire. | Assessed during day of screening examination | No |
| Secondary | Belief That Surgery Will be Painful | Measured as a percentage of subjects who agree with the statement in a questionnaire. | Assessed during day of screening examination | No |
| Secondary | Belief That Vision Will Improve "a Lot" Following Surgery | Measured as a percentage of subjects who agree with the statement in a questionnaire. | Assessed during day of screening examination | No |
| Secondary | Belief That Surgeons at the Hospital Are "Highly Skilled" | Measured as a percentage of subjects who agree with the statement in a questionnaire. | Assessed during day of screening examination | No |
| Secondary | Belief That Doctors and Nurses at the Hospital Have "Very Good" Attitudes | Measured as a percentage of subjects who agree with the statement in a questionnaire. | Assessed during day of screening examination | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
| Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
| Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
| Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
| Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
| Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
| Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
| Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
| Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
| Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
| Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
| Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
| Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
| Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
| Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
| Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
| Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
| Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
| Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
| Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |